During the past decade, Texas Tech University Health Sciences Center School of Medicine conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Tech University Health Sciences Center School of Medicine" #1 sponsor was "Children's Oncology Group" with 25 trials, followed by "National Cancer Institute (NCI)" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Texas Tech University Health Sciences Center" with 3 trials sponsored and "National Institutes of Health Clinical Center (CC)" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Tech University Health Sciences Center School of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Texas Tech University Health Sciences Center School of Medicine" are "Leukemia" (9 trials), "Sarcoma" (6 trials), "Neuroblastoma" (5 trials), "Brain and Central Nervous System Tumors" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Texas Tech University Health Sciences Center School of Medicine" in a lesser frequency.

Most popular intervention types in "Texas Tech University Health Sciences Center School of Medicine" are "Drug" (31 trials), "Biological" (13 trials), "Procedure" (13 trials), "Radiation" (11 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (13 trials), "filgrastim" (13 trials), "etoposide" (11 trials), "radiation therapy" (11 trials) and "vincristine sulfate" (8 trials). Other intervention names were less common.

The vast majority of trials in "Texas Tech University Health Sciences Center School of Medicine" are 31 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Texas Tech University Health Sciences Center School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Texas Tech University Health Sciences Center School of Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Tech University Health Sciences Center School of Medicine, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".